You are viewing: South Korea In Vitro Fertilization Market analysis
Part of: In Vitro Fertilization Market (Global)

The South Korea In Vitro Fertilization Market was valued at $30.2 Million in 2024 and projected to reach to $50.2 Million by 2029, representing a compound annual growth rate of 10.7%. South Korea's in vitro fertilization market is poised for sustained growth through 2029, driven by demographic shifts, delayed marriage ages, and increased infertility prevalence among the population.

South Korea In Vitro Fertilization Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea In Vitro Fertilization Market Trends and Insights

  • This expansion reflects South Korea's advanced healthcare infrastructure, increasing awareness of fertility treatments, and rising demand for assisted reproductive technologies among couples facing infertility challenges.
  • South Korea's aging population and delayed childbearing trends are driving adoption of IVF services across the country. The South Korea IVF market is supported by high healthcare spending, well-established fertility clinics, and favorable reimbursement policies that enhance patient accessibility.
  • South Korea's strong emphasis on medical innovation and technology integration positions the nation as a regional leader in reproductive medicine.
  • Between 2024 and 2029, South Korea is expected to see accelerated market penetration as awareness campaigns and improved treatment success rates encourage more couples to pursue fertility solutions..

Key Market Statistics

  • CAGR (2024-2029) 10.7% CAGR
  • Market Size, 2024 ~USD 30.2 Million
  • Forecast, 2029 ~USD 50.2 Million
  • Country South Korea

South Korea In Vitro Fertilization Market Overview

Market Valuation Growth :

South Korea's IVF market is valued at USD 30.2 million in 2024, with a projected CAGR of 10.7%, reaching USD 50.2 million by 2029, demonstrating strong market expansion driven by increasing fertility treatment demand.

Advanced Healthcare Infrastructure :

South Korea possesses world-class medical facilities and cutting-edge reproductive technology centers, positioning it as a regional leader in assisted reproductive technologies and attracting both domestic and international patients.

Rising Infertility Awareness :

Increasing public awareness campaigns and reduced social stigma surrounding fertility treatments have significantly boosted demand for IVF services among South Korean couples, particularly in urban centers like Seoul and Busan.

Government Support & Subsidies :

South Korea's government initiatives providing financial assistance and insurance coverage for fertility treatments have made IVF more accessible, driving market growth and expanding patient demographics across income levels.

South Korea In Vitro Fertilization Market Dynamics

  • The government's commitment to supporting fertility treatments through subsidies and insurance coverage expansion will continue to enhance market accessibility and patient volume.
  • South Korea's reputation for medical excellence and technological innovation positions it competitively within the Asian IVF market.
  • Emerging trends include personalized treatment protocols, genetic screening advancements, and integration of AI-driven diagnostics.
  • The market will likely see consolidation among fertility clinics and increased investment in research and development, further strengthening South Korea's position as a regional fertility treatment hub..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • South Korea's IVF market is valued at USD 30.2 million in 2024 and is forecast to reach USD 50.2 million by 2029, representing a 10.7% CAGR.
      • South Korea's advanced healthcare infrastructure and high medical spending support rapid adoption of assisted reproductive technologies.
      • Delayed childbearing and an aging population in South Korea are key demographic drivers fueling IVF market expansion.
      • South Korea's favorable reimbursement policies and well-established fertility clinic network enhance patient accessibility and market growth potential.

      In Vitro Fertilization Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment FROZEN NON-DONORS (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 11.7% from 2024 to 2029
      Largest Segment EQUIPMENT (Product)
      Market Size Base Year (Billions) ~USD 0.95 (2024)
      Revenue Forecast (Billions) ~USD 1.65 (2029)
      Segments Covered Product, Type, Type Of Cycle, Procedure, End User

      South Korea In Vitro Fertilization Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Accessories
      • Anti-Vibration Tables
      • Cabinets
      • Cryosystems
      • Equipment
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Ovum Aspiration Pumps
      • Reagents & Media
      • Sperm Analyzer Systems
      • Sperm Separation Systems
      • Witness Systems

      By Type

      • Anti-Vibration Tables
      • Cabinets
      • Cryopreservation Media
      • Cryosystems
      • Embryo Culture Media
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Other Incubators
      • Ovum Aspiration Pumps
      • Ovum Processing Media
      • Sperm Analyzer Systems
      • Sperm Processing Media
      • Sperm Separation Systems
      • Time-Lapse Incubators
      • Witness Systems

      By Type Of Cycle

      • Fresh Donors
      • Fresh Non-Donors
      • Frozen Donors
      • Frozen Non-Donors

      By Procedure

      • Conventional Ivf
      • Ivf With Donar Eggs
      • Ivf With Icsi
      • Minimal Ivf
      • Other Procedures

      By End User

      • Cryobanks
      • Fertility Clinics & Ivf Centers
      • Hospitals & Surgical Centers
      • Hospitals & Surgical Clinics
      • Research Institutes

      Target Audience

      • Fertility Clinic Operators : South Korean fertility clinic owners and operators need market data to benchmark performance, identify growth opportunities, optimize service offerings, and make informed expansion decisions in a competitive landscape.
      • Healthcare Investors & PE Firms : Investment firms targeting South Korea's healthcare sector require detailed market analysis, growth projections, and competitive intelligence to evaluate IVF market opportunities and assess portfolio company potential.
      • Medical Device & Pharmaceutical Companies : Manufacturers of IVF equipment, medications, and diagnostic tools need South Korea-specific market data to identify distribution opportunities, understand regulatory requirements, and develop localized go-to-market strategies.
      • Insurance & Healthcare Payers : Insurance companies and healthcare administrators need market insights on IVF treatment costs, patient volumes, and reimbursement trends to optimize coverage policies and manage claims in South Korea's fertility market.
      • Market Research & Consulting Firms : Research organizations and consultants require granular South Korea IVF market data to support client advisory work, competitive analysis, and strategic planning across healthcare and life sciences sectors.

      Reasons to Buy this Report

      • Market Size & Growth Projections : Access precise valuation data for South Korea's IVF market (USD 30.2M in 2024) with detailed 5-year forecasts, enabling accurate investment planning and revenue projections specific to this high-growth market segment.
      • Competitive Landscape Analysis : Understand South Korea's fertility clinic ecosystem, key players, market consolidation trends, and competitive positioning to identify partnership opportunities and market entry strategies in this advanced healthcare market.
      • Government Policy & Reimbursement Insights : Gain detailed intelligence on South Korean government subsidies, insurance coverage policies, and regulatory frameworks affecting IVF accessibility and market dynamics, critical for healthcare providers and insurers.
      • Patient Demographics & Demand Drivers : Analyze South Korea-specific demographic trends, infertility prevalence rates, patient behavior patterns, and cultural factors influencing IVF adoption to tailor marketing and service delivery strategies effectively.
      • Technology & Innovation Trends : Identify emerging technologies, genetic screening advancements, and AI integration in South Korean fertility clinics to stay ahead of innovation curves and benchmark against regional best practices.

      Frequently asked questions

      What is the current size of South Korea's IVF market?

      South Korea's in vitro fertilization market was valued at USD 30.2 million in 2024 and is expected to grow to USD 50.2 million by 2029.

      What is the projected growth rate for South Korea's IVF market?

      South Korea's IVF market is projected to grow at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2029.

      What factors are driving growth in South Korea's IVF market?

      Key growth drivers in South Korea include an aging population, delayed childbearing trends, advanced healthcare infrastructure, favorable reimbursement policies, and increasing awareness of fertility treatments.

      How does South Korea's IVF market compare to other Asia Pacific countries?

      South Korea maintains a strong position in the Asia Pacific region due to its advanced medical technology, high healthcare spending, well-established fertility clinics, and supportive regulatory environment for assisted reproductive technologies.

      What is the forecast market size for South Korea's IVF market by 2029?

      South Korea's IVF market is forecast to reach USD 50.2 million by 2029, up from USD 30.2 million in 2024.

      RESEARCH METHODOLOGY

      In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.

      Secondary Research

      The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.

      Primary Research

      Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.

      A breakdown of the primary respondents is provided below:

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1  billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.

      Market Estimation Methodology

      This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.

      The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are

      • Draw up a list of key global players operating in the in vitro fertilization market. Map the annual revenues accrued by players from the in vitro fertilization market or nearest reported business unit/ product category.
      • It represents the current major share of the global market as of 2022, using revenue mapping of the key players.

      Extrapolation to the global value for the in vitro fertilization market. Global In vitro fertilization Market: Bottom-Up Approach

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Global In vitro fertilization Market : Top-Down Approach

      In Vitro Fertilization Market Size, and Share

      In Vitro Fertilization Market Size, and Share

      Data Triangulation

      The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.

      Market Definition

      The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.

      Key Stakeholders

      • Manufacturers and distributors of In vitro fertilization devices
      • Healthcare institutions (Hospitals and clinics)
      • Surgical centers
      • Healthcare institutions (hospitals and cardiac centers)
      • Research institutions
      • Clinical research organizations
      • Academic Medical Centers and Universities
      • Reference labs
      • Clinical research organizations
      • Accountable Care Organizations (ACOs)
      • Research and consulting firms
      • Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
      • Academic medical centers and universities
      • Market research and consulting firms
      • Surgery Centers
      • Group Purchasing Organizations (GPOs)
      • Medical Research Laboratories
      • Academic Medical Centers and Universities

      Objectives of the Study

      • Define, describe, and forecast the In vitro fertilization market on Product, cycle, procedure, end user and region.
      • Analyze opportunities in the market for stakeholders and details of the competitive landscape for market leaders.
      • Detailed information regarding major factors influencing the market growth.
      • Analysis of the micro markets with respect to individual growth trends, prospects, and contribution to the total market.
      • Tracking and analysis of competitive developments such as new product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the in vitro fertilization market.
      • Description of key companies operating in the market along with their market share analysis and core competencies

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market

      Product Analysis

      • Product matrix, which gives a detailed comparison of the product portfolios of the top 5 companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe's In vitro fertilization market: Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
      • Further breakdown of the Rest of Asia Pacific In vitro fertilization market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
      • Further breakdown of the Rest of the world In vitro fertilization market: Latin America, MEA, and Africa

      Get the Full In Vitro Fertilization Market Report

      Full forecast, segment splits, and company analysis for all In Vitro Fertilization Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status